These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
674 related items for PubMed ID: 27595453
41. Identification of carbapenem-resistant Pseudomonas aeruginosa in selected hospitals of the Gulf Cooperation Council States: dominance of high-risk clones in the region. Zowawi HM, Syrmis MW, Kidd TJ, Balkhy HH, Walsh TR, Al Johani SM, Al Jindan RY, Alfaresi M, Ibrahim E, Al-Jardani A, Al Salman J, Dashti AA, Sidjabat HE, Baz O, Trembizki E, Whiley DM, Paterson DL. J Med Microbiol; 2018 Jun; 67(6):846-853. PubMed ID: 29664716 [Abstract] [Full Text] [Related]
42. High incidence of type III secretion system associated virulence factors (exoenzymes) in Pseudomonas aeruginosa isolated from Iranian burn patients. Khodayary R, Nikokar I, Mobayen MR, Afrasiabi F, Araghian A, Elmi A, Moradzadeh M. BMC Res Notes; 2019 Jan 15; 12(1):28. PubMed ID: 30646938 [Abstract] [Full Text] [Related]
43. Antimicrobial Resistance and Type III Secretion System Virulotypes of Pseudomonas aeruginosa Isolates from Dogs and Cats in Primary Veterinary Hospitals in Japan: Identification of the International High-Risk Clone Sequence Type 235. Hayashi W, Izumi K, Yoshida S, Takizawa S, Sakaguchi K, Iyori K, Minoshima KI, Takano S, Kitagawa M, Nagano Y, Nagano N. Microbiol Spectr; 2021 Oct 31; 9(2):e0040821. PubMed ID: 34585944 [Abstract] [Full Text] [Related]
47. Diverse Genetic Background of Multidrug-Resistant Pseudomonas aeruginosa from Mainland China, and Emergence of an Extensively Drug-Resistant ST292 Clone in Kunming. Fan X, Wu Y, Xiao M, Xu ZP, Kudinha T, Bazaj A, Kong F, Xu YC. Sci Rep; 2016 May 20; 6():26522. PubMed ID: 27198004 [Abstract] [Full Text] [Related]
48. Detection of synergistic antimicrobial resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from post-operative wound infections. Awan AB, Yan A, Sarwar Y, Schierack P, Ali A. Appl Microbiol Biotechnol; 2021 Dec 20; 105(24):9321-9332. PubMed ID: 34797390 [Abstract] [Full Text] [Related]
49. Molecular characterisation of antimicrobial resistance in Pseudomonas aeruginosa and Acinetobacter baumannii during 2014 and 2015 collected across India. Pragasam AK, Vijayakumar S, Bakthavatchalam YD, Kapil A, Das BK, Ray P, Gautam V, Sistla S, Parija SC, Walia K, Ohri VC, Anandan S, Veeraraghavan B. Indian J Med Microbiol; 2016 Dec 20; 34(4):433-441. PubMed ID: 27934820 [Abstract] [Full Text] [Related]
50. Molecular epidemiological survey of the quinolone- and carbapenem-resistant genotype and its association with the type III secretion system in Pseudomonas aeruginosa. Ferreira ML, Dantas RC, Faria ALS, Gonçalves IR, Silveira de Brito C, Queiroz LL, Gontijo-Filho PP, Ribas RM. J Med Microbiol; 2015 Mar 20; 64(Pt 3):262-271. PubMed ID: 25596115 [Abstract] [Full Text] [Related]
52. [Molecular epidemiology and antibiotic resistance of Pseudomonas aeruginosa isolated from blood in a hospital in Shandong Province from 2014 to 2021]. Wang JZ, Dong XT, Zhang XN, Deng P, Cheng F, Ma WS. Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct 06; 57(10):1558-1564. PubMed ID: 37859371 [Abstract] [Full Text] [Related]
53. VIM-1, VIM-2, and GES-5 Carbapenemases Among Pseudomonas aeruginosa Isolates at a Tertiary Hospital in Istanbul, Turkey. Malkoçoğlu G, Aktaş E, Bayraktar B, Otlu B, Bulut ME. Microb Drug Resist; 2017 Apr 06; 23(3):328-334. PubMed ID: 27326514 [Abstract] [Full Text] [Related]
56. Determination of carbapenem resistance mechanism in clinical isolates of Pseudomonas aeruginosa isolated from burn patients, in Tehran, Iran. Mirsalehian A, Kalantar-Neyestanaki D, Taherikalani M, Jabalameli F, Emaneini M. J Epidemiol Glob Health; 2017 Sep 06; 7(3):155-159. PubMed ID: 28756823 [Abstract] [Full Text] [Related]
57. Coexistence of metallo-beta-lactamase-encoding genes in Pseudomonas aeruginosa. Mohanam L, Menon T. Indian J Med Res; 2017 Jul 06; 146(Supplement):S46-S52. PubMed ID: 29205195 [Abstract] [Full Text] [Related]
58. Carbapenemase-producing Pseudomonas aeruginosa in Spain: interregional dissemination of the high-risk clones ST175 and ST244 carrying blaVIM-2, blaVIM-1, blaIMP-8, blaVIM-20 and blaKPC-2. PÉrez-VÁzquez M, Sola-Campoy PJ, Zurita ÁM, Ávila A, GÓmez-Bertomeu F, SolÍs S, LÓpez-Urrutia L, GÓnzalez-BarberÁ EM, Cercenado E, Bautista V, Lara N, Aracil B, Oliver A, Campos J, Oteo-Iglesias J, Spanish Antibiotic Resistance Surveillance Program collaborating Group. Int J Antimicrob Agents; 2020 Jul 06; 56(1):106026. PubMed ID: 32450200 [Abstract] [Full Text] [Related]
59. Emergence of rmtD1 gene in clinical isolates of Pseudomonas aeruginosa carrying blaKPC and/or blaVIM-2 genes in Brazil. Costa-Júnior SD, da Silva AMCM, Niedja da Paz Pereira J, da Costa Lima JL, Cavalcanti IMF, Maciel MAV. Braz J Microbiol; 2021 Dec 06; 52(4):1959-1965. PubMed ID: 34420185 [Abstract] [Full Text] [Related]
60. Low-level resistance and clonal diversity of Pseudomonas aeruginosa among chronically colonized cystic fibrosis patients. Ferreira AG, Leão RS, Carvalho-Assef AP, da Silva ÉA, Firmida Mde C, Folescu TW, Paixão VA, Santana MA, de Abreu e Silva FA, Barth AL, Marques EA. APMIS; 2015 Dec 06; 123(12):1061-8. PubMed ID: 26522829 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]